Updated 30 days ago
421 Rose Avenue Garretson, SD 57030
Braasch Biotech LLC is a privately held, preclinical stage Vaccine Company that specializes in the discovery, early stage development and commercialization of an exciting new class of biopharmaceutical vaccine products for the human and animal healthcare market. Our Cross Platform Utilization of Vaccination (CPUV™) is a paradigm shift in the field of Vaccinology... In 2008 Braasch Biotech LLC made the strategic decision to focus solely on the development and commercialization of the world's first highly effective somatostatin-based vaccines and companion adjuvant systems. Our approach was designed to produce both highly innovative and socially responsible vaccines for global impact... Braasch's platform technology has significant opportunities to create a large pipeline of new products. Delivering new treatments, categories and segments for innovative Growth Hormone ("GH") and Insulin-like Growth Factor -1 ("IGF-1") treatment alternatives which address some of the highest valued..
Also known as: Braasch Biotech LLC